英国首席医疗官活动对英格兰抗生素处方的影响:中断时间序列分析
该研究利用1998至2017年年度处方成本分析数据及2010年10月至2018年6月月度处方数据,以STAR-PU标化抗生素处方率,采用中断时间序列分析评估2013年英国首席医疗官强调「强有力行动」及五年抗菌药物耐药战略后的处方变化。结果显示2013年后处方率斜率下降,抗生素处方率由2013年的1378/1000 STAR-PU降至2017年的1184/1000 STAR-PU,降幅14.1%。
要点
- 2013年后抗生素处方率斜率下降,每年每1000 STAR-PU减少46.4个处方项。
- 处方率从2013年1378降至2017年1184/1000 STAR-PU,降幅14.1%。
- 作者不能确证因果关系,但变化幅度与时间点值得注意。
核心结论
- 2013年后英格兰NHS初级保健抗生素处方率出现明显下降,但作者不能将下降 firmly 归因于五年抗菌药物耐药战略。
研究设计与样本
- 研究为中断时间序列分析,使用1998至2017年年度处方成本分析数据和2010年10月至2018年6月月度处方数据。
- 抗生素处方率以年龄和性别调整的STAR-PU为分母计算。
主要发现
- 2013年后处方率斜率变化为每年每1000 STAR-PU减少46.4个处方项(95% CI = -61.4 to -31.3)。
- 处方率从2013年的1378/1000 STAR-PU每年降至2017年的1184/1000 STAR-PU,降幅14.1%。
- 月度数据显示降幅为16.4%。
临床怎么用
- 提示国家层面抗菌药物管理战略与首席医疗官倡导可能伴随初级保健抗生素处方量下降,可作为抗菌药物管理成效评估的背景参考。
局限性
- 作者明确不能 firmly 将处方下降归因于五年抗菌药物耐药战略。
- 研究为观察性时间序列分析,未报告其他可能影响处方趋势的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance is a growing problem, with the need for 'strong action' highlighted by the Chief Medical Officer for England in 2013, along with a 5 year antimicrobial resistance strategy. OBJECTIVES: Five years on, we set out to determine if there was a measurable impact from the 5 year antimicrobial resistance strategy on overall antibiotic prescribing in NHS primary care in England. METHODS: We calculated the volume of antibiotic prescription items using annual prescription cost analysis data from 1998 to 2017 and monthly prescribing data from October 2010 to June 2018. Antibiotic prescribing rate was calculated using an age- and sex-adjusted denominator (Specific Therapeutic group Age-sex Related Prescribing Units, STAR-PU). We conducted interrupted time series analysis to measure any change in prescribing rate after the intervention. RESULTS: After several years with a stable rate of antibiotic prescribing, there was a downward change in gradient after 2013: -46.4 items per 1000 STAR-PU per year (95% CI = -61.4 to -31.3). The prescribing rate dropped from 1378 per 1000 STAR-PU per year in 2013 to 1184 in 2017, representing a 14.1% reduction. The reduction is similar for monthly data (16.4%). Assuming causality, when compared with predicted prescribing if the rate of prescribing had continued at the pre-2013 trend, we estimate that 9.7 million antibiotic prescriptions were prevented over the past year by the 5 year antimicrobial resistance strategy. CONCLUSIONS: Though we cannot firmly attribute causality for the reduction in prescribing to the 5 year antimicrobial resistance strategy, the magnitude and timing of the change are noteworthy; the substantial change followed a long period of relatively static antibiotic prescribing.
引用
- Walker AJ, Curtis HJ, Goldacre B, et al. Impact of Chief Medical Officer activity on prescribing of antibiotics in England: an interrupted time series analysis. J Antimicrob Chemother. 2019. PMID: 30689889. doi:10.1093/jac/dky528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。